# Spironolactone

## Spironolactone 25mg

| TAH Drug Code      | [OSPI](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=OSPI)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|:-------------------|:-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Diuresis Acne Ascites, Refractory; Diagnosis Ascites - Cirrhosis of liver Cirrhosis of liver - Edema Edema - Nephrotic syndrome Heart failure, NYHA class III or IV Heart failure with normal ejection fraction Hirsutism Hyperaldosteronism Hypertension, Add-on therapy Primary aldosteronism                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| Dosing             | Diuretic-induced hypokalemia: 25-100 mg/day in 2-4 divided doses. Congestive cardiac failure/Liver cirrhosis/Nephrotic syndrome, Edematous disorders: Initially, 25-200 mg/day in 2-4 divided doses, administer for at least 5 days before increasing dose to obtain desired effect. Maintenance dose: 75-400 mg/day in 2-4 divided doses. Hypertension: 50-100 mg/day given in divided doses or as a single daily dose. For difficult or severe cases, gradually increased at 2-weekly intervals up to 200 mg/day. Hyperaldosteronism: Preparation for surgery: 100-400 mg/day in 2-4 divided doses. Long-term therapy for patients unsuitable for surgery: use lowest effective dosage. Children: Initial daily dose approximately 1-3 mg/kg in a single or divided doses, administer for at least 5 days before increasing dose to obtain desired effect. |
| Hepatic Impairment | Dose adjustment required                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| Renal Impairment   | Dose adjustment required                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| Contraindications  | Addison disease Concomitant eplerenone use Hyperkalemia                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| Adverse Effects    | GI symptoms; drowsiness; lethargy; headache; cutaneous eruptions; urticaria; mental confusion; drug fever; ataxia; impotence; amenorrhea; post-menopausal bleeding; gynecomastia; rarely agranulocytosis.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| Pregnancy          | No (Limited) Human Data â€“ Animal Data Suggest Risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| Lactation          | No (Limited) Human Data - Probably Compatible                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| More Info          | [UpToDate](https://www.uptodate.com/contents/spironolactone-drug-information)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |

